» Authors » Kevin Petrecca

Kevin Petrecca

Explore the profile of Kevin Petrecca including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 98
Citations 3449
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Berry D, Moldoveanu D, Rajkumar S, Lajoie M, Lin T, Tchelougou D, et al.
Cell Rep . 2025 Mar; 44(3):115365. PMID: 40023845
Hotspot BRAF, hotspot NRAS, and NF1 loss-of-function mutations are found in approximately 50%, 25%, and 15% of cutaneous melanomas, respectively. Compared to mutant BRAF and NRAS, the role of NF1...
2.
Miller T, El Farran C, Couturier C, Chen Z, DAntonio J, Verga J, et al.
Nature . 2025 Feb; PMID: 40011771
Gliomas are incurable malignancies notable for having an immunosuppressive microenvironment with abundant myeloid cells, the immunomodulatory phenotypes of which remain poorly defined. Here we systematically investigate these phenotypes by integrating...
3.
Daoust F, Dallaire F, Tavera H, Ember K, Guiot M, Petrecca K, et al.
Sci Rep . 2025 Feb; 15(1):6453. PMID: 39987144
Intraoperative Raman spectroscopy uses near-infrared laser light to gain molecular information without causing damage. It can be used in vivo or ex vivo without exogenous contrast agents. Clinically, the technique...
4.
Almansouri A, Yang A, Djedid A, Emara A, Nadaf J, Petrecca K
Neurosurg Pract . 2025 Feb; 6(1):e00127. PMID: 39958481
Background And Objectives: By convention, patients who have undergone a craniotomy for tumor are monitored in a neurocritical care unit (NCCU) overnight, yet there is little evidence to justify the...
5.
Leblond F, Dallaire F, Ember K, Le Moel A, Blanquez-Yeste V, Tavera H, et al.
J Biomed Opt . 2025 Jan; 30(1):010501. PMID: 39866856
Significance: Maximal safe resection of brain tumors can be performed by neurosurgeons through the use of accurate and practical guidance tools that provide real-time information during surgery. Current established adjuvant...
6.
Lazaratos A, Bian D, Petrecca K, Guiot M, Dankner M
Transl Lung Cancer Res . 2025 Jan; 13(12):3824-3830. PMID: 39830768
No abstract available.
7.
Najafian K, Rehany B, Nowakowski A, Ghazimoghadam S, Pierre K, Zakarian R, et al.
Neurooncol Adv . 2024 Dec; 6(1):vdae200. PMID: 39679176
Background: Brain metastasis invasion pattern (BMIP) is an emerging biomarker associated with recurrence-free and overall survival in patients, and differential response to therapy in preclinical models. Currently, BMIP can only...
8.
Jamali F, Lan K, Daniel P, Petrecca K, Sabri S, Abdulkarim B
Antioxidants (Basel) . 2024 Oct; 13(10). PMID: 39456455
Glioblastoma (GBM) is an incurable primary brain cancer characterized by increased reactive oxygen species (ROS) production. The redox-sensitive tumor suppressor gene , wild-type (wt) for 70% of patients, regulates redox...
9.
Pellerin D, Mereaux J, Boluda S, Danzi M, Dicaire M, Davoine C, et al.
Brain . 2024 Oct; PMID: 39378335
Spinocerebellar ataxia 27B (SCA27B) is a common autosomal dominant ataxia caused by an intronic GAA•TTC repeat expansion in FGF14. Neuropathological studies have shown that neuronal loss is largely restricted to...
10.
Roux A, Saadi T, Luo M, Le P, Diaz R, Petrecca K
Neurochirurgie . 2024 Sep; 70(6):101599. PMID: 39341335
No abstract available.